$MYGN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MYRIAD GENETICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in MYRIAD GENETICS INC. Get notifications about new insider transactions in MYRIAD GENETICS INC for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 23 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16 2016 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Option Exercise | M | 23.98 | 4,170 | 99,997 | 0 | |
| Jun 16 2016 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Buy | M | 23.98 | 4,170 | 99,997 | 73,309 | 69.1 K to 73.3 K (+6.03 %) |
| Apr 05 2016 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 14.88 | 15,000 | 223,200 | 3,120 | |
| Apr 05 2016 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 38.12 | 15,000 | 571,800 | 80,640 | 95.6 K to 80.6 K (-15.68 %) |
| Apr 05 2016 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 14.88 | 15,000 | 223,200 | 95,640 | 80.6 K to 95.6 K (+18.60 %) |
| Apr 08 2016 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 18.00 | 15,000 | 270,000 | 4,445 | |
| Apr 08 2016 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 39.03 | 15,000 | 585,450 | 80,640 | 95.6 K to 80.6 K (-15.68 %) |
| Apr 08 2016 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 18.00 | 15,000 | 270,000 | 95,640 | 80.6 K to 95.6 K (+18.60 %) |
| Dec 14 2015 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Sell | S | 42.23 | 5,000 | 211,150 | 12,500 | 17.5 K to 12.5 K (-28.57 %) |
| Dec 09 2015 | MYGN | MYRIAD GENETICS IN ... | Phanstiel S. Louise | Director | Sell | S | 44.00 | 5,000 | 220,002 | 5,000 | 10 K to 5 K (-50.00 %) |
| Dec 07 2015 | MYGN | MYRIAD GENETICS IN ... | Phanstiel S. Louise | Director | Gift | G | 0.00 | 10,000 | 0 | 8,500 | -1,500 to 8.5 K (-666.67 %) |
| Dec 07 2015 | MYGN | MYRIAD GENETICS IN ... | Phanstiel S. Louise | Director | Grant | A | 0.00 | 7,500 | 0 | 18,500 | 11 K to 18.5 K (+68.18 %) |
| Dec 07 2015 | MYGN | MYRIAD GENETICS IN ... | BEST LAWRENCE C | Director | Grant | A | 0.00 | 7,500 | 0 | 17,500 | 10 K to 17.5 K (+75.00 %) |
| Dec 07 2015 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Grant | A | 0.00 | 7,500 | 0 | 17,500 | 10 K to 17.5 K (+75.00 %) |
| Dec 07 2015 | MYGN | MYRIAD GENETICS IN ... | DREISMANN HEINRICH | Director | Grant | A | 0.00 | 7,500 | 0 | 17,500 | 10 K to 17.5 K (+75.00 %) |
| Dec 07 2015 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Grant | A | 0.00 | 7,500 | 0 | 17,500 | 10 K to 17.5 K (+75.00 %) |
| Dec 07 2015 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Grant | A | 0.00 | 7,500 | 0 | 21,500 | 14 K to 21.5 K (+53.57 %) |
| Nov 05 2015 | MYGN | MYRIAD GENETICS IN ... | DREISMANN HEINRICH | Director | Option Exercise | M | 27.61 | 30,000 | 828,300 | 0 | |
| Nov 05 2015 | MYGN | MYRIAD GENETICS IN ... | DREISMANN HEINRICH | Director | Option Exercise | M | 25.39 | 30,000 | 761,700 | 0 | |
| Nov 05 2015 | MYGN | MYRIAD GENETICS IN ... | DREISMANN HEINRICH | Director | Sell | S | 44.44 | 30,000 | 1,333,059 | 10,000 | 40 K to 10 K (-75.00 %) |
| Nov 05 2015 | MYGN | MYRIAD GENETICS IN ... | DREISMANN HEINRICH | Director | Buy | M | 27.61 | 30,000 | 828,300 | 40,000 | 10 K to 40 K (+300.00 %) |
| Nov 05 2015 | MYGN | MYRIAD GENETICS IN ... | DREISMANN HEINRICH | Director | Sell | S | 44.44 | 30,000 | 1,333,059 | 10,000 | 40 K to 10 K (-75.00 %) |
| Nov 05 2015 | MYGN | MYRIAD GENETICS IN ... | DREISMANN HEINRICH | Director | Buy | M | 25.39 | 30,000 | 761,700 | 40,000 | 10 K to 40 K (+300.00 %) |
| Nov 05 2015 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Option Exercise | M | 22.93 | 35,000 | 802,550 | 0 | |
| Nov 05 2015 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Sell | S | 44.50 | 35,000 | 1,557,500 | 68,384 | 103.4 K to 68.4 K (-33.85 %) |
| Nov 05 2015 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Buy | M | 22.93 | 35,000 | 802,550 | 103,384 | 68.4 K to 103.4 K (+51.18 %) |
| Nov 05 2015 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Gift | G | 0.00 | 1,739 | 0 | 68,384 | 70.1 K to 68.4 K (-2.48 %) |
| Nov 05 2015 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Gift | G | 0.00 | 2,628 | 0 | 70,123 | 72.8 K to 70.1 K (-3.61 %) |
| Oct 28 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 23.98 | 10,000 | 239,800 | 11,830 | |
| Oct 28 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 42.82 | 10,000 | 428,200 | 80,573 | 90.6 K to 80.6 K (-11.04 %) |
| Oct 28 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 23.98 | 10,000 | 239,800 | 90,573 | 80.6 K to 90.6 K (+12.41 %) |
| Oct 28 2015 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | M | 22.93 | 50,962 | 1,168,559 | 0 | |
| Oct 28 2015 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 41.86 | 50,962 | 2,133,269 | 70,737 | 121.7 K to 70.7 K (-41.88 %) |
| Oct 28 2015 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 22.93 | 50,962 | 1,168,559 | 121,699 | 70.7 K to 121.7 K (+72.04 %) |
| Oct 27 2015 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | M | 22.93 | 5,038 | 115,521 | 50,962 | |
| Oct 27 2015 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | M | 16.53 | 7,298 | 120,636 | 0 | |
| Oct 27 2015 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | M | 16.53 | 11,491 | 189,946 | 7,298 | |
| Oct 27 2015 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | M | 16.53 | 940 | 15,538 | 18,789 | |
| Oct 27 2015 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 41.80 | 5,038 | 210,588 | 70,737 | 75.8 K to 70.7 K (-6.65 %) |
| Oct 27 2015 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 22.93 | 5,038 | 115,521 | 75,775 | 70.7 K to 75.8 K (+7.12 %) |
| Oct 27 2015 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 41.80 | 7,298 | 305,056 | 70,737 | 78 K to 70.7 K (-9.35 %) |
| Oct 27 2015 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 16.53 | 7,298 | 120,636 | 78,035 | 70.7 K to 78 K (+10.32 %) |
| Oct 27 2015 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 41.80 | 11,491 | 480,324 | 70,737 | 82.2 K to 70.7 K (-13.97 %) |
| Oct 27 2015 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 16.53 | 11,491 | 189,946 | 82,228 | 70.7 K to 82.2 K (+16.24 %) |
| Oct 27 2015 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 41.80 | 940 | 39,292 | 70,737 | 71.7 K to 70.7 K (-1.31 %) |
| Oct 27 2015 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 16.53 | 940 | 15,538 | 71,677 | 70.7 K to 71.7 K (+1.33 %) |
| Oct 19 2015 | MYGN | MYRIAD GENETICS IN ... | Riggsbee Richard Bryan | Chief Financial Off ... | Payment of Exercise | F | 39.31 | 2,427 | 95,405 | 27,573 | 30 K to 27.6 K (-8.09 %) |
| Oct 07 2015 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Option Exercise | M | 30.34 | 3,861 | 117,143 | 0 | |
| Oct 07 2015 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Option Exercise | M | 30.12 | 2,346 | 70,662 | 0 | |
| Oct 07 2015 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Option Exercise | M | 16.53 | 1 | 17 | 0 | |
| Oct 07 2015 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Buy | M | 30.34 | 3,861 | 117,143 | 72,751 | 68.9 K to 72.8 K (+5.60 %) |
| Oct 07 2015 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Buy | M | 30.12 | 2,346 | 70,662 | 68,890 | 66.5 K to 68.9 K (+3.53 %) |
| Oct 07 2015 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Buy | M | 16.53 | 1 | 17 | 66,544 | 66.5 K to 66.5 K (0.00 %) |
| Oct 07 2015 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Gift | G | 0.00 | 1,000 | 0 | 73,227 | 74.2 K to 73.2 K (-1.35 %) |
| Sep 22 2015 | MYGN | MYRIAD GENETICS IN ... | McDade Ralph L | President Myriad RB ... | Payment of Exercise | F | 41.39 | 2,188 | 90,561 | 55,157 | 57.3 K to 55.2 K (-3.82 %) |
| Sep 22 2015 | MYGN | MYRIAD GENETICS IN ... | McDade Ralph L | President Myriad RB ... | Grant | A | 0.00 | 24,000 | 0 | 57,345 | 33.3 K to 57.3 K (+71.97 %) |
| Sep 17 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Payment of Exercise | F | 41.39 | 5,400 | 223,506 | 80,573 | 86 K to 80.6 K (-6.28 %) |
| Sep 17 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Grant | A | 0.00 | 34,500 | 0 | 85,973 | 51.5 K to 86 K (+67.03 %) |
| Sep 17 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Payment of Exercise | F | 41.39 | 5,400 | 223,506 | 80,573 | 86 K to 80.6 K (-6.28 %) |
| Sep 17 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Grant | A | 0.00 | 34,500 | 0 | 85,973 | 51.5 K to 86 K (+67.03 %) |
| Sep 17 2015 | MYGN | MYRIAD GENETICS IN ... | Wenstrup Richard | Chief Medical Offic ... | Payment of Exercise | F | 41.39 | 931 | 38,534 | 22,069 | 23 K to 22.1 K (-4.05 %) |
| Sep 17 2015 | MYGN | MYRIAD GENETICS IN ... | Wenstrup Richard | Chief Medical Offic ... | Grant | A | 0.00 | 11,500 | 0 | 23,000 | 11.5 K to 23 K (+100.00 %) |
| Sep 17 2015 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | M | 18.06 | 10,000 | 180,600 | 0 | |
| Sep 17 2015 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | M | 16.53 | 270 | 4,463 | 19,729 | |
| Sep 17 2015 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | M | 16.53 | 50,000 | 826,500 | 19,999 | |
| Sep 17 2015 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 41.39 | 270 | 11,175 | 70,737 | 71 K to 70.7 K (-0.38 %) |
| Sep 17 2015 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 16.53 | 270 | 4,463 | 71,007 | 70.7 K to 71 K (+0.38 %) |
| Sep 17 2015 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Payment of Exercise | F | 41.39 | 6,897 | 285,467 | 70,737 | 77.6 K to 70.7 K (-8.88 %) |
| Sep 17 2015 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 39.88 | 10,000 | 398,791 | 77,634 | 87.6 K to 77.6 K (-11.41 %) |
| Sep 17 2015 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 18.06 | 10,000 | 180,600 | 87,634 | 77.6 K to 87.6 K (+12.88 %) |
| Sep 17 2015 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Sell | S | 39.88 | 50,000 | 1,993,955 | 77,634 | 127.6 K to 77.6 K (-39.17 %) |
| Sep 17 2015 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 16.53 | 50,000 | 826,500 | 127,634 | 77.6 K to 127.6 K (+64.40 %) |
| Sep 17 2015 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Option Exercise | M | 22.93 | 35,000 | 802,550 | 35,000 | |
| Sep 17 2015 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Payment of Exercise | F | 41.39 | 6,684 | 276,651 | 67,543 | 74.2 K to 67.5 K (-9.00 %) |
| Sep 17 2015 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Sell | S | 41.25 | 35,000 | 1,443,750 | 74,227 | 109.2 K to 74.2 K (-32.04 %) |
| Sep 17 2015 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Buy | M | 22.93 | 35,000 | 802,550 | 109,227 | 74.2 K to 109.2 K (+47.15 %) |
| Sep 17 2015 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Payment of Exercise | F | 41.39 | 11,671 | 483,063 | 136,026 | 147.7 K to 136 K (-7.90 %) |
| Sep 17 2015 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | President, MGL | Payment of Exercise | F | 41.39 | 1,937 | 80,172 | 34,094 | 36 K to 34.1 K (-5.38 %) |
| Sep 17 2015 | MYGN | MYRIAD GENETICS IN ... | Ford Alexander | President, MGL | Grant | A | 0.00 | 16,500 | 0 | 36,031 | 19.5 K to 36 K (+84.48 %) |
| Sep 16 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 19.47 | 14,562 | 283,522 | 57,432 | |
| Sep 16 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 39.41 | 14,562 | 573,888 | 51,473 | 66 K to 51.5 K (-22.05 %) |
| Sep 16 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 19.47 | 14,562 | 283,522 | 66,035 | 51.5 K to 66 K (+28.29 %) |
| Sep 08 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 19.47 | 25,438 | 495,278 | 71,994 | |
| Sep 08 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 39.41 | 25,438 | 1,002,512 | 51,473 | 76.9 K to 51.5 K (-33.07 %) |
| Sep 08 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 19.47 | 25,438 | 495,278 | 76,911 | 51.5 K to 76.9 K (+49.42 %) |
| Sep 02 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 18.00 | 15,000 | 270,000 | 19,445 | |
| Sep 02 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 38.23 | 15,000 | 573,450 | 51,473 | 66.5 K to 51.5 K (-22.57 %) |
| Sep 02 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 18.00 | 15,000 | 270,000 | 66,473 | 51.5 K to 66.5 K (+29.14 %) |
| Aug 31 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 14.88 | 30,000 | 446,400 | 18,120 | |
| Aug 31 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 35.73 | 30,000 | 1,071,900 | 51,473 | 81.5 K to 51.5 K (-36.82 %) |
| Aug 31 2015 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 14.88 | 30,000 | 446,400 | 81,473 | 51.5 K to 81.5 K (+58.28 %) |
| Aug 14 2015 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Grant | A | 0.00 | 58,754 | 0 | 77,634 | 18.9 K to 77.6 K (+311.20 %) |
| Aug 14 2015 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Grant | A | 0.00 | 56,946 | 0 | 74,227 | 17.3 K to 74.2 K (+329.53 %) |
| Aug 14 2015 | MYGN | MYRIAD GENETICS IN ... | Capone Mark Christopher | President & C.E.O. | Grant | A | 0.00 | 99,429 | 0 | 147,697 | 48.3 K to 147.7 K (+205.99 %) |
| May 08 2015 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Option Exercise | M | 18.00 | 5,555 | 99,990 | 0 | |
| May 08 2015 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Buy | M | 18.00 | 5,555 | 99,990 | 10,424 | 4.9 K to 10.4 K (+114.09 %) |
| May 08 2015 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Gift | G | 0.00 | 6,000 | 0 | 540 | 6.5 K to 540 (-91.74 %) |
| Mar 03 2015 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Option Exercise | M | 18.00 | 5,555 | 99,990 | 0 | |
| Mar 03 2015 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Buy | M | 18.00 | 5,555 | 99,990 | 16,778 | 11.2 K to 16.8 K (+49.50 %) |
| Mar 03 2015 | MYGN | MYRIAD GENETICS IN ... | MARSH RICHARD M | E.V.P., General Cou ... | Gift | G | 0.00 | 5,324 | 0 | 11,223 | 16.5 K to 11.2 K (-32.18 %) |
| Jan 06 2015 | MYGN | MYRIAD GENETICS IN ... | Tobin Bernard | President Crescendo ... | Payment of Exercise | F | 34.61 | 4,720 | 163,359 | 35,280 | 40 K to 35.3 K (-11.80 %) |
| Jan 06 2015 | MYGN | MYRIAD GENETICS IN ... | Tobin Bernard | President Crescendo ... | Grant | A | 0.00 | 28,000 | 0 | 40,000 | 12 K to 40 K (+233.33 %) |
| Jan 06 2015 | MYGN | MYRIAD GENETICS IN ... | Tobin Bernard | President Crescendo ... | Grant | A | 0.00 | 12,000 | 0 | 12,000 | 0 to 12 K |
| Dec 04 2014 | MYGN | MYRIAD GENETICS IN ... | Phanstiel S. Louise | Director | Grant | A | 0.00 | 10,000 | 0 | 11,000 | 1,000 to 11 K (+1,000.00 %) |
| Dec 04 2014 | MYGN | MYRIAD GENETICS IN ... | LANGER DENNIS | Director | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Dec 04 2014 | MYGN | MYRIAD GENETICS IN ... | DREISMANN HEINRICH | Director | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Dec 04 2014 | MYGN | MYRIAD GENETICS IN ... | GILBERT WALTER PHD | Director | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Dec 04 2014 | MYGN | MYRIAD GENETICS IN ... | HENDERSON JOHN T | Director | Grant | A | 0.00 | 10,000 | 0 | 14,000 | 4 K to 14 K (+250.00 %) |
| Dec 04 2014 | MYGN | MYRIAD GENETICS IN ... | BEST LAWRENCE C | Director | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Nov 06 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Option Exercise | M | 23.11 | 4,328 | 100,020 | 0 | |
| Nov 06 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Option Exercise | M | 16.53 | 1 | 17 | 0 | |
| Nov 06 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Buy | M | 16.53 | 1 | 17 | 10,869 | 10.9 K to 10.9 K (+0.01 %) |
| Nov 06 2014 | MYGN | MYRIAD GENETICS IN ... | MELDRUM PETER D | President & C.E.O. | Buy | M | 23.11 | 4,328 | 100,020 | 10,868 | 6.5 K to 10.9 K (+66.18 %) |
| Nov 06 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | M | 23.11 | 4,328 | 100,020 | 0 | |
| Nov 06 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Option Exercise | M | 16.53 | 1 | 17 | 0 | |
| Nov 06 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 16.53 | 1 | 17 | 18,880 | 18.9 K to 18.9 K (+0.01 %) |
| Nov 06 2014 | MYGN | MYRIAD GENETICS IN ... | LANCHBURY JERRY S | Chief Scientific Of ... | Buy | M | 23.11 | 4,328 | 100,020 | 18,879 | 14.6 K to 18.9 K (+29.74 %) |
| Oct 20 2014 | MYGN | MYRIAD GENETICS IN ... | Riggsbee Richard Bryan | Chief Financial Off ... | Grant | A | 0.00 | 30,000 | 0 | 30,000 | 0 to 30 K |
| Nov 05 2014 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Option Exercise | M | 19.47 | 6,568 | 127,879 | 97,432 | |
| Nov 05 2014 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Sell | S | 39.95 | 6,568 | 262,392 | 50,698 | 57.3 K to 50.7 K (-11.47 %) |
| Nov 05 2014 | MYGN | MYRIAD GENETICS IN ... | King Gary A. | Exec. VP Internatio ... | Buy | M | 19.47 | 6,568 | 127,879 | 57,266 | 50.7 K to 57.3 K (+12.96 %) |
| Oct 02 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 9.04 | 4,978 | 45,001 | 24,358 | |
| Oct 02 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 8.63 | 16,872 | 145,605 | 0 | |
| Oct 02 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 38.99 | 16,872 | 657,804 | 48,128 | 65 K to 48.1 K (-25.96 %) |
| Oct 02 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 8.63 | 16,872 | 145,605 | 65,000 | 48.1 K to 65 K (+35.06 %) |
| Oct 02 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 38.99 | 4,978 | 194,082 | 48,128 | 53.1 K to 48.1 K (-9.37 %) |
| Oct 02 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 9.04 | 4,978 | 45,001 | 53,106 | 48.1 K to 53.1 K (+10.34 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 30.12 | 75,864 | 2,285,024 | 8,790 | |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 30.12 | 3,000 | 90,360 | 84,654 | |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 30.12 | 2,346 | 70,662 | 0 | |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 23.11 | 4,328 | 100,020 | 0 | |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 16.53 | 1 | 17 | 0 | |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 13.28 | 5,324 | 70,703 | 0 | |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 12.17 | 5,808 | 70,683 | 0 | |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 9.04 | 664 | 6,003 | 0 | |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Option Exercise | M | 8.63 | 13,128 | 113,295 | 0 | |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 38.08 | 75,864 | 2,889,098 | 48,128 | 124 K to 48.1 K (-61.18 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 30.12 | 75,864 | 2,285,024 | 123,992 | 48.1 K to 124 K (+157.63 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 37.98 | 3,000 | 113,940 | 48,128 | 51.1 K to 48.1 K (-5.87 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 30.12 | 3,000 | 90,360 | 51,128 | 48.1 K to 51.1 K (+6.23 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 37.51 | 13,128 | 492,431 | 48,128 | 61.3 K to 48.1 K (-21.43 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 8.63 | 13,128 | 113,295 | 61,256 | 48.1 K to 61.3 K (+27.28 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 37.51 | 664 | 24,907 | 48,128 | 48.8 K to 48.1 K (-1.36 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 9.04 | 664 | 6,003 | 48,792 | 48.1 K to 48.8 K (+1.38 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 37.34 | 5,808 | 216,853 | 48,128 | 53.9 K to 48.1 K (-10.77 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 12.17 | 5,808 | 70,683 | 53,936 | 48.1 K to 53.9 K (+12.07 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 37.34 | 5,324 | 198,782 | 48,128 | 53.5 K to 48.1 K (-9.96 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 13.28 | 5,324 | 70,703 | 53,452 | 48.1 K to 53.5 K (+11.06 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Sell | S | 37.51 | 2,346 | 87,998 | 48,128 | 50.5 K to 48.1 K (-4.65 %) |
| Sep 23 2014 | MYGN | MYRIAD GENETICS IN ... | Evans James S | Chief Financial Off ... | Buy | M | 30.12 | 2,346 | 70,662 | 50,474 | 48.1 K to 50.5 K (+4.87 %) |